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ABSTRACT 
We demonstrate centrifugal [liquid handling] 
automation of an Enzyme-Linked Immuno-Sorbent Assay 
(ELISA) for the detection of anti-p53 antibodies in whole 
blood. On this “Lab-on-a-Disc” (LoaD) platform, all unit 
operations were implemented by event-triggered rota-
tional flow control. In order to avoid interference during 
absorbance measurement from the solid phase in this 
heterogeneous assay format, it is pivotal that the inter-
mediate reaction product is eventually forwarded from the 
incubation chamber to a distinct optical measurement 
chamber. To this end we have devised routing of flows by 
lipophilic film valves (LFVs) which remain intact in 
aqueous and selectively dissolve when exposed to an 
ancillary, oleophilic solvent. 
 
INTRODUCTION 
In this work we specifically consider centrifugal 
microfluidic systems towards the development of 
conceptually simple and cost-efficient bioanalytical point-
of-care (POC) applications [1]. The full integration and 
automation of underlying liquid handling protocols while 
keeping the instrumentation compact and cost-efficient is 
a common design goal of these “Lab-on-a-Disc” (LoaD) 
systems [2]. As during spinning all liquids are subject to 
the same radial force field, valves have to be opened se-
lectively in time and space for implementing sequential 
and parallel process steps. Many early-stage LoaD sys-
tems have introduced capillary barriers or siphons to 
orchestrate flow control. Recent developments showed the 
integration of functional materials into microfluidics [3], 
for instance disc-based ferrowax plugs were molten by an 
external laser [4], thus increasing the complexity of the 
instrument. Also centrifugo-pneumatic dissolvable films 
(DF) valves were presented which are opened by rota-
tionally induced contact with aqueous solutions such as 
most biosamples and reagents [5]. 
We introduce here a novel, sacrificial membrane 
which is dissolvable in lipophilic liquids. This flow 
control element initially blocks aqueous solutions until an 
ancillary, oleophilic liquid is introduced from its back side 
to route the next aqueous solution, e.g. an elution buffer, 
to designated outlet. This event-triggered [5] router is 
implemented to demonstrate the on-disc integration of a 
bead-based, i.e. heterogeneous immunoassay. 
In comparison to planar surfaces in bioassays, micro-
particle based assays provide much higher surface area 
thus substantially improving performance and have hence 
found direct applications in various areas like 
immunoassay formats (e.g.: ELISA) and bioprocessing 
steps like purification and extraction [6]. Typically such 
applications feature several steps of washing and 
incubation. Bead-based ELISAs are an essential tool for 
the detection of antigens and antibodies for clinical 
diagnostics. The final step in such assays is commonly the 
reaction of the enzymatic substrate in the bead column 
(immobilized capture antibodies on bead surface in the 
reaction chamber) and then eventual quenching with an 
acid before measuring the absorbance values. In an 
automated point-of-care ELISA, the absorbance 
measurement is ideally performed on disc, thus requiring 
a clear pathway for optical detection. The presence of a 
solid phase hence makes it mandatory to route the 
eventual enzymatic substrate away from the reaction 
chamber to a final quenching / measurement chamber to 
avoid any disturbance in absorbance measurements of the 
end product. 
In LoaD systems, this has been accomplished 
previously by using laser-actuated valves [4]. We address 
this issue by introducing a routing mechanism based on 
lipophilic membranes that are selectively dissolved on 
demand by an immiscible liquid. This “transistor mode” 
operation with an ancillary liquid makes them particularly 
interesting since the routing does not require any 
additional instrumentation other than the simple spindle 
motor while allowing purely rotational flow control over 
the fluid flow. 
Using lipophilic membrane routing, we present here 
the integration of a multi-step ELISA assay encompassing 
plasma separation from whole blood, incubation with 
capture antibodies on beads, multiple buffer washes and 
eventual routing of post-reaction enzymatic substrate to a 
measurement chamber performed on the disc in its en-
tirety based on event-triggered rotational flow control [5].  
 
SYSTEM DESIGN 
Lipophilic valve based routing 
Lipophilic membranes are biocompatible materials 
[7] that are hydrophobic in nature and selectively dissolve 
in bio-reagent grade oleophilic solvents such as light oil 
[8]. When in contact with an aqueous solutions, the 
hydrophobic nature of the membrane keeps the liquid 
from wetting and dissolving it. On the contrary, oleophilic 
solvents wet and dissolve the membranes while being 
immiscible with aqueous solutions. This implies that the 
membranes can act as a solvent-selective, intermediate 
barrier between two channels. Additionally, due to their 
softness and plasticity, they can be easily assembled into 
multi-layer valve composites cut into shapes.  
We have devised a 3D structure to integrate such 
membranes into our microfluidic flow system (Fig.1). The 
lipophilic membrane is integrated under a microchannel in 
order to restrict the flow of aqueous solutions, acting as a 
transient barrier for fluid communication between two 
separate channels. When an aqueous solution is required 
to be routed from the top channel away from the normal 
exit, the lipophilic membrane is dissolved by mineral oil 
to open up the second channel and direct the subsequent 
aqueous solution into a designated chamber. (Fig.2) 
 
Figure 1: Lipophilic membrane based router. Cross 
section shows the placement of the valves inside the 
router. (Yellow tab- Lipophilic membrane, Blue tab- DF, 
Red layers-PSA; Black layers- PMMA). When the 
lipophilic valve is triggered, the aqueous solution from 
the inlet channel A routes to channel C instead of the 
usual channel B. 
 
Figure 3 shows a fully integrated system for a disc-
based ELISA for the detection of anti-p53 antibodies in 
whole blood. Individual components are: A) plasma 
extraction, B) reagent storage, C) bead incubation with 
surface-immobilized p53 capture antibody, D) waste, E) 
pneumatic chamber and F) the solvent-selective router. 
The vector of dissolvable-film valves in the waste (D) 
orchestrates the serial release of wash and ELISA reagents 
to the incubation chamber (C) as well as the ancillary 
liquid originally stored in chamber F to the back of the 
lipophilic membrane. Mixing in (C) is boosted by its 
centrifugo-pneumatic coupling to the compression 
chamber E while swiftly varying the spin rate. The incu-
bation chamber (C) features two outlets, one of them lead-
ing via a siphon to the waste (D). The second outlet is 
initially sealed by a lipophilic membrane and opened to 
the detection chamber G by introducing the oleophilic an-
cillary liquid (F) from the reverse side.  
 
In the first steps of the ELISA, sample, wash and 
reagents are routed from their respective reservoirs (A, 
B1-4) through the incubation chamber (C) where they are 
rotationally stirred and subsequently guided through the 
siphon into the waste (D). The final trigger concurrently 
releases the colour-generating enzymatic substrate (TMB) 
into C as well as the ancillary liquid to wet the first lipo-
philic valve. The concurrent dissolution from the backside 
of the second lipophilic membrane in the routing chamber 
with the ancillary liquid then routes the TMB from the 
reaction chamber through the centrifugally preferred 
outlet to G where the preloaded acid quenches the reac-
tion before absorbance detection (Fig.2). 
 
METHODOLOGY 
Disc fabrication and assembly 
The LoaD is an eight layered structure composed of 
four layers of poly methyl-methacrylate (PMMA, 1.5 mm 
thick) bonded by intermediate pressure sensitive adhesive 
sheets (PSA, 86 µm) as shown in Fig.4. All features on 
the PMMA layers (Disc OD 130 mm, vents, reservoirs, 
router components) were laser ablated (30-W CO2 laser, 
Epilog, USA). The PSA layers were structured with a 
knife cutter (Graphtec, Japan). The topmost PSA layer 
consists of the bulk of the microchannels connecting the 
reservoirs containing the sequence of unit operations of 
the ELISA. Appropriate air exits are engraved in the 
PMMA layer above this in the top Vents layer. 
 
 
 
Figure 2: Trigger and release mechanism for the lipophilic-film valves (LFV) for routing of aqueous solutions. The aim 
is to route the final liquid from the incubation chamber (containing beads) to the detection chamber rather than across 
the siphon to waste. Red and yellow arrows indicate flow of aqueous and oleophilic ancillary liquid, respectively. Please 
note that steps II through IV are performed at spin frequency higher than the critical frequency of the siphon. (I) 
Aqueous solution from incubation chamber flows over to waste through the siphon triggering the release of the ancillary 
liquid in the routing fluid chamber. (II) DF13 valve triggers the ancillary liquid to wet the LFV1. (III) Once LFV1 is 
dissolved, the oleophilic liquid flows to the Router (engraved in a lower layer) and wets LFV2 but not the DF14. (IV) 
LFV2 is dissolved in the ancillary liquid releasing the aqueous solution from the incubation into the routing chamber 
where it phase separates below because of higher density enabled by centrifugally induced stratification of aqueous and 
oleophilic phases. (V) The aqueous solution wets DF14 thus opening up the channel to the detection chamber as in 
Section VI. 
 
 
Figure 3: ELISA miniaturization on a centrifugal microfluidic Lab-on-a-Disc (LoaD) platform with event flow. The 
LoaD integrates all assay steps ranging from plasma extraction to the eventual absorbance measurement for 
quantification. The disc architecture is constituted by chambers for: A) plasma extraction, B) reagent storage (BW-buffer 
wash, HRP-Ab – bioconjugate of HRP with secondary antibody, TMB- substrate), C) incubation, D) waste, F) router 
(highlighted in yellow are the elements of the lipophilic routing mechanism) and G) detection chamber. Dissolvable-film 
valves (DFs) in the segments of the waste chamber (D) event-trigger the successive release of liquids along the ELISA. 
The final dissolution of the lipophilic film valve (LFV2) at the other outlet of (C), routes the final TMB solution to detec-
tion chamber (Fig.2). 
 
The reservoir PMMA layer includes storage, incubation 
chambers and waste chambers. The DF and lipophilic 
membrane valves are sandwiched in between the DF 
support and DF cover PSA layers. The lower air channels 
PSA layer includes the pneumatic connections that are the 
core of the event-triggered structure allowing the release 
of reagents, buffer washes and the routing fluid on the 
disc. The lowest Base PMMA layer contains the vent for 
the router and seals the lower channels. All microchannels 
are 500 µm wide except for the oleophilic liquid (which 
measures 800 µm). All features of the device were de-
signed using SolidWorks 2013 (Dassault systems, USA). 
Routing of the fluids using DF valves and event-triggered 
formation was accomplished as demonstrated before [5]. 
Protocol for anti-p53 antibody ELISA 
A 140-µl blood sample is centrifuged for 5 minutes in 
the separation chamber to extract a plasma volume of 
40 µl. This metered volume is incubated with the 
preloaded capture antibody + p53 protein coated beads in 
the incubation chamber for 10 minutes. During these 
steps, the mixing is induced by pulsed compression / 
decompression of a pneumatic chamber connected to the 
main incubation chamber (Fig. 3). Thereafter the beads 
are washed with the first buffer wash of 80 µl for 30 se-
conds. This is followed by incubation of the beads with 
the HRP tagged Secondary Antibody (40 µl) for 10 
minutes. Then the final buffer wash (80 µl) is released and 
it incubates with the beads for 30 seconds. The last trigger 
after this wash eventually releases the enzymatic substrate 
TMB (40 µl) and also the ancillary oleophilic liquid. The 
TMB incubates for 7 minutes with the beads to undergo 
color change to blue.  The LFV router sets the point in 
time for the release of the TMB from the incubation 
chamber to the final detection chamber. The reaction is 
then quenched by the pre-loaded 40 µl of acid in the final 
measurement chamber. The resulting solution is measured 
for absorbance at 425 nm. 
 
Figure 4: 3D render of 
the exploded view of the 
eight layered ELISA disc 
showing transparent 
PMMA layers with 
intermediate PSA layers 
(red) for bonding. In 
descending order from 
the top: 1. Vents, 2. 
Micro-channel, 3. Reser-
voirs, 4. DF Cover, 5. DF 
support, 6. Valving routes 
layer, 7.  Lower air 
channels, 8. Base with 
vents. 
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RESULTS 
Microfluidic testing 
A fully operational microfluidic routing of a fluid 
using a lipophilic membrane is demonstrated in Fig. 2. 
The purpose is to route an aqueous fluid from the main 
incubation chamber to the detection chamber as opposed 
to the normal route that is taken by the aqueous solution 
across the siphon. In a multi-step operation the last liquid 
to enter the waste event triggers the release of the oleo-
philic solution into the router. The sequential dissolution 
of the two lipophilic membranes in the router arrangement 
(LFV1 and LFV2) by the ancillary liquid eventually trig-
gers the release of the aqueous solution from the incu-
bation chamber into the router. Here the wetting of the 
DF14 valve by the aqueous solution (assisted by the 
centrifugal stratification due to lower density ancillary 
liquid) opens up the channel leading to the detection 
chamber. 
Effect of reduced reagent/buffer volumes on ELISA 
sensitivity 
One of the most important aspects of moving to a 
microfluidic platform from the standard bench-top ELISA 
protocol is the significant reduction in the volumes of the 
reagents and the buffer washes. For on-disc implemen-
tation, standard volumes used on 96 well plates (100 µl) 
were reduced to 40 µl for the TMB and Sec-Ab conjugate, 
and two single intermediate 80 µl for the buffer washes 
(instead of two 100 µl 3X washes i.e. 300 µl each wash). 
Figure 5 summarizes the results for the detection of the 
anti-p53 antibody on a well plate using the reduced on-
disc volumes; the limit of detection (LOD) was 
determined as 0.7 ng ml-1. In comparison to data from 
bench-top protocol, we found no significant reduction in 
the sensitivity of the ELISA (data not shown). 
 
Figure 5: Detection of anti-p53 antibodies using ELISA 
with on-disc 40-µl volume (2.5 times lower than the bench 
top protocol) for reagents and a single 80-µl wash buffer. 
Average optical density of WT p53 proteins probed with 
monoclonal anti-p53 antibodies and detected using HRP 
secondary IgG is plotted against concentration (realizing 
an LOD of 0.7 ng ml-1.) 
 
DISCUSSION AND CONCLUSION 
We have integrated selectively dissolvable lipophilic 
membranes into a centrifugal microfluidic platform for 
routing of aqueous solutions without the need for external 
actuation modules on the instrument other than a simple, 
frequency-controlled spindle motor. We have shown its 
direct applicability for bead-based ELISAs where further 
downstream sample handling is required before eventual 
detection. This is a significant improvement on current 
systems that require complex instrumentation approach 
for such routing. We also have demonstrated a fully 
functional microfluidic system for a bead-based-ELISA to 
detect anti-p53 antibodies in blood. 
Further steps will include the optimization of the on-
disc protocol of the ELISA. We also plan to extend the 
platform to further clinically relevant antibodies towards a 
flexible point-of-care device. Such a lab-on-a-disc system 
holds significant potential where intensive instrumenta-
tion and sample preparation are least desired. 
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